Dr Robin Sanderson

Dr Sanderson completed his Haematological training at Guy's and St Thomas', King's College and St Bartholomew's Hospitals in London as well as fellowships in Sydney teaching hospitals. He completed his Haematology training in 2014 and was a Clinical Lecturer in Haemato-oncology at Barts Cancer Institute until 2019. He completed his PhD investigating CAR-T cells in chronic lymphocytic leukaemia and lymphoma and their modulation with immunotherapy in pre-clinical models at Barts Cancer Institue, Queen Mary University of London. He is an expert in lymphoma and CAR-T cells and was appointed at King's College Hospital in 2019 to lead the lymphoma CAR-T programme and has been chief and principal investigator on a number of CAR-T trials in lymphoid disorders. He is the apheresis lead at King's College Hospital for haemato-oncology.